The term *critical illness* has been widely used for many years to describe the condition of any patient with illness severe enough to be considered at risk for death. In modern general medical and surgical intensive care units (ICUs), where at least 25 percent of patients may have this condition,[@bib1] it has become synonymous with the syndrome of sepsis and multiple organ failure. This syndrome has probably always been a component of preterminal illness, but before the advent of modern methods of treatment, the syndrome evolved so quickly that the nature of the preterminal events was not considered. However, with the use of intravenous transfusions, antibiotics, activated protein C, and improvements in assisted ventilation, patients are now kept alive for days, weeks, and even months in intensive or critical care units, and as many as 40 percent recover.[@bib1], [@bib2] Thus, it is now possible to study the syndrome in detail, and its effects on the various major organ systems, including the central and peripheral nervous systems.

In the past, sepsis was defined as the systemic response to dividing and invading microorganisms of all types. However, in many instances the offending organism cannot be cultured. For example, blood cultures are negative in half of the patients suspected of being septic. Moreover, the criteria for diagnosing sepsis based on systemic responses are still unsettled. The term *systemic inflammatory response syndrome* (SIRS) should now be applied to a severe clinical insult that arises not only as the result of infection but also as the result of noninfectious processes such as trauma, burns, and pancreatitis.[@bib3] The chief clinical features of this syndrome are two or more of the following: (1) temperature exceeding 38°C or less than 36°C, (2) heart rate greater than 90 beats/min, (3) respiratory rate greater than 20 breaths/min or arterial partial pressure of carbon dioxide (Paco~2~) less than 32 torr (4.3 kPa), and (4) white blood cell count (WBC) more than 12,000 cells/mm^3^ or with more than 10 percent immature (band) forms.[@bib3] SIRS may be accompanied by hypotension (blood pressure less than 90 mmHg or a reduction of more than 40 mmHg from baseline in the absence of other causes of hypotension).[@bib4]

In SIRS, cellular and humoral responses are activated[@bib2], [@bib5] to produce changes in the microcirculation throughout the body ([Fig. 52-1](#f1){ref-type="fig"} ). The cellular response involves epithelial and endothelial cells, macrophages, and neutrophils. These induce the humoral response; proinflammatory mediators are activated locally and include interleukins-1, -2, and -6, tumor necrosis factor (TNF)--α, arachidonic acid, coagulation factors, free oxygen radicals, and proteases. These cellular and humoral factors interact with themselves and with adhesion molecules, which are increased in the blood of septic patients.[@bib6] Adhesion molecules adhere to leukocytes, platelets, and endothelial cells; they also induce "rolling neutrophils" and fibrin platelet aggregates that obstruct capillary flow. Endothelial damage increases capillary permeability, which induces local tissue edema. Levels of protein C are reduced in sepsis.[@bib2] Endothelial damage impairs the endothelium-dependent activation of protein C, thus shifting the balance to thrombosis.[@bib7], [@bib8] Activation of nitric oxide, now known to be the endovascular relaxing factor, causes arteriolar dilation, which may further slow capillary flow. Thus, essential nutrients fail to reach the organ parenchyma. For example, despite adequate oxygenation via mechanical ventilation, there is a severe oxygen debt at the parenchymal level contributing to multiple organ dysfunction.[@bib5] Considering the profound disturbances of the microcirculation and the impaired delivery of substrates, especially oxygen and glucose, upon which the nervous system depends, it is not surprising that the nervous system is affected. There is no known specific treatment, but it is known that if the underlying sepsis can be brought under control by either medical or surgical means, the various manifestations of the syndrome disappear and full recovery is possible.FIGURE 52-1Schematic, theoretical presentation of disturbances in the microcirculation to various organs, including brain, peripheral nerve, and muscle, in systemic inflammatory response syndrome (SIRS). The result is impaired perfusion due to excessive vasodilatation through overproduction of nitric oxide, and aggregation of cellular elements through activation of adhesion molecules and deactivation of protein C. Increased capillary permeability causes edema and the potential for entry of toxic substances.(Adapted with permission from Bolton CF: Neuromuscular manifestations of critical illness. Muscle Nerve 32:140, 2005.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

The patients who are most susceptible are those suffering from multiple injuries or severe medical illness or who have just had major surgery, particularly if they are elderly or have serious underlying disease that may affect their resistance to infection. Early intubation and transfer to the critical care unit is usually necessary. In the course of time, various intravascular lines are inserted, either for treatment or to monitor vital function. There is little doubt that these invasive procedures induce the state of sepsis if it was not already present. Thus, it is generally recognized that patients who have been in the unit for more than 5 days almost invariably become septic and, if that is not controlled, soon develop the syndrome of multiple organ failure.

Either the central or peripheral nervous systems may be affected in 70 percent of patients with sepsis and multiple organ failure.[@bib9] Within hours of the onset of sepsis, a mild encephalopathy develops, termed *septic* or *sepsis-associated encephalopathy.* [@bib9] When deterioration to a state of multiple organ failure occurs, this encephalopathy becomes severe, but it soon subsides if the sepsis is successfully treated. However, the clinician may then note that it is difficult to wean the patient from the mechanical ventilator. If lung and heart disease are excluded, *critical illness polyneuropathy, critical illness myopathy,* or a combination of both (*critical illness neuromyopathy)* is almost always the cause of this circumstance.[@bib10] However, as with encephalopathy, the polyneuropathy or myopathy eventually disappears if the sepsis does not recur and the patient survives.

SEPTIC (SEPSIS-ASSOCIATED) ENCEPHALOPATHY {#cesec1}
=========================================

The term *septic encephalopathy* refers to altered brain function related to the presence of microorganisms or their toxins in the blood. This condition has been recognized by surgeons and internists as a component of multiple organ failure, but it has received little systematic study.

Clinical Features {#cesec2}
-----------------

The clinical diagnosis of septic encephalopathy is one of exclusion. Altered brain function in the febrile patient can be due to a number of conditions other than the sepsis itself ([Table 52-1](#cetable1){ref-type="table"} ). Space does not allow a complete discussion of the differential diagnosis, butother entities can usually be ruled out by the history, physical examination, and laboratory tests. It is often necessary to perform a lumbar puncture to exclude bacterial meningitis.TABLE 52-1Causes of Encephalopathy in Febrile Patients***Infections***Central nervous systemBacterial: meningitis, cerebritis, brain abscess, subdural/epidural empyemaViral: encephalitisOther: spirochetal, rickettsial, protozoal, helminthicIntracranial thrombophlebitisBacterial endocarditis: may produce embolism, meningitis, mycotic aneurysmSystemic infectionDirect organ damage, e.g., hepatitisSeptic encephalopathy***Vascular Accidents***Pulmonary emboliCNS: vertebrobasilar stroke, intracranial hemorrhage***Mechanical Causes (Trauma)***Cerebral injuryFat embolism (fractures of long bones)***Immunological Conditions***Drug feverAcetylsalicylic acid toxicityConnective tissue disease***Heat Stroke**Metabolic Conditions***Acute adrenal failureThyroid storm (hyperthyroidism)Porphyria***Reye\'s Syndrome (Children)**Neoplasms***Systemic malignancy with organ failureBrain tumors, primary or secondary: affecting thermoregulation***Hematological Causes***Hemolytic episodes, e.g., sickle cell diseaseLeukemia***Increased Muscular Activity***Convulsive seizuresMalignant neuroleptic syndrome

We carried out a retrospective study on 12 autopsied patients[@bib11] and a separate clinical, prospective study involving 69 patients, each with fever and either a positive blood culture or a localized bacterial or fungal infection as inclusion criteria.[@bib12] Patients with a fever and either a positive blood culture or a localized bacterial or fungal infection were included for both studies. We excluded patients younger than 16 years and those with central nervous system (CNS) disorders unrelated to the febrile illness, preexisting metabolic disorders, and conditions that affect the brain other than by a septic mechanism. In the prospective study, we also excluded patients receiving heavy sedation or analgesics and those receiving skeletal muscle relaxants. For this study, using an arbitrary set of bedside criteria, we classified patients as nonencephalopathic, mildly encephalopathic, and severely encephalopathic. In our classification, nonencephalopathic patients cooperated with testing and passed a series of tests of attention, concentration, orientation, and short-term memory. The mildly encephalopathic patients completed testing but failed to "pass," and the severely encephalopathic patients were too obtunded to test.

The clinical picture is similar to that of diffuse or multifocal encephalopathy in general. The level of consciousness varies from clouding of consciousness to coma. Delirium occurs infrequently, preceding stupor or coma. Mildly encephalopathic patients often show considerable fluctuation in their clinical state, and older individuals become especially confused at night. Attention, concentration, and memory are impaired. Writing disturbances occur, as in other acute confusional states. Paratonic rigidity, or *gegenhalten* (a rate-dependent resistance to passive movement), is almost universal in encephalopathic patients. Tremor, asterixis, and multifocal myoclonus occur in 10 to 25 percent of noncomatose encephalopathic patients. Alterations of pupillary size or reaction, abnormalities of individual cranial nerves, focal neurological signs, or convulsive seizures typically do not occur. Hemiparesis or gaze palsy was found in 6 and focal or generalized convulsive seizures occurred in 5 of the 12 patients in our retrospective (autopsy) series, but were rare in our prospective study. The difference may be accounted for, in part, by the duration of sepsis in the autopsy group and the pathological findings (discussed later).

As expected, the mortality rate in our prospective study was significantly greater among the severely encephalopathic patients than in the other groups.[@bib12] Nearly half of the severely encephalopathic patients but none of the nonencephalopathic patients died. About 25 percent of the nonencephalopathic patients had clinical and electrophysiological evidence of mild peripheral neuropathy. Among the moderately and severely encephalopathic patients, 50 percent and 75 percent, respectively, had critical illness polyneuropathy; among the patients in the latter group, the polyneuropathy was usually severe.[@bib12] The time courses of the encephalopathy and the polyneuropathy often differed. The encephalopathy peaked earlier and cleared long before the polyneuropathy in the course of the septic illness. Some severely encephalopathic patients were obtunded for a month or more, but CNS function improved soon after the infection and systemic metabolic problems were controlled or resolved.

There was a strong association of adult respiratory distress syndrome with severe encephalopathy. Transient hypotension was more common at the onset of sepsis in the severely encephalopathic patients, although there was no difference in blood pressure among the three groups at their initial neurological assessment. The degree of prior hypotension was not sufficient to account for the neurological findings. Interestingly, none of the following correlated with the severity of encephalopathy: age (a trend for correlation of age and degree of encephalopathy did not achieve statistical significance), gender, temperature, or type of organism (no difference between gram-positive and gram-negative organisms, but patients with *Candida,* although few in number, were more severely affected).

Laboratory Features {#cesec3}
-------------------

The electroencephalogram (EEG) is a sensitive monitor of septic encephalopathy. We found it to be more sensitive than our arbitrary clinical assessment of mental status, in that some nonencephalopathic patients had mild EEG abnormalities that resolved on subsequent recordings. The mildest EEG change consisted of mild, generalized slowing (theta activity). More severe EEG abnormalities, which correlated with more profound depression of consciousness, consisted of greater slowing (delta activity), triphasic waves, or a burst-suppression pattern ([Fig. 52-2](#f2){ref-type="fig"} ).[@bib13] Using computational nonlinear analysis techniques, Straver and colleagues showed that EEG features correlated with the severity of illness and that the EEG became disorganized with greater severity of illness, suggesting a shift in the processing ability of the brain.[@bib14] Although there is a direct relationship between the degree of EEG abnormality and mortality, some patients with even the most severe categories of abnormality recover. Thus, the EEG cannot be used to predict a hopeless prognosis in septic encephalopathy.[@bib13], [@bib14] FIGURE 52-2Electroencephalograms (EEGs) from patients with septic encephalopathy. **A,** Patient with mild encephalopathy. The EEG shows a mild excess of low-voltage 6- to 7-Hz theta rhythms in both left (odd-numbered electrode placements) and right (even-numbered placements) hemispheres. **B** to **D,** Severely encephalopathic patients. **B,** Bilateral intermittent rhythmic delta (\<3 Hz) waves on a background of mild slowing. **C,** Triphasic waves. **D,** Burst-suppression pattern.

Serum levels of creatinine and bilirubin showed a direct, linear correlation with the severity of the encephalopathy.[@bib13] Although hyperventilation is a feature of sepsis, there were no significant differences in blood pH, bicarbonate, or Pco~2~ among the three groups. In our retrospective study, a drop in platelet count was associated with the development of brain purpura and neurological signs.

We did not find any abnormalities in the cerebrospinal fluid (CSF) or on unenhanced computed tomography (CT) brain scans in any of our patients, including those who showed microabscesses at autopsy.[@bib13]

Using transcranial Doppler studies, Straver and colleagues have shown an increase in cerebral mean and end-diastolic flow velocities in the brains of patients with septic encephalopathy.[@bib15] The severity of the systemic sepsis correlated with the increased flow velocity. This finding implies that patients with severe septic encephalopathy are at risk for ischemic cerebral damage. As a corollary, care should be taken to avoid hyperventilation in such patients. The drop in Paco~2~ could lead to a further decrease in cerebral perfusion.

Autopsy Findings {#cesec4}
----------------

In our autopsy series, 8 of the 12 patients had disseminated microabscesses in the brain, chiefly in the cerebral cortex and subcortical white matter. Because there was some reaction in the brain around the microabscesses, these lesions did not appear to be just agonal phenomena.

Four patients had increased protoplasmic astrocytes in the cerebral cortex. They were unrelated to the microabscesses and probably reflected a metabolic encephalopathy. Three patients had central pontine myelinolysis, a condition that has been related to overcorrection of hyponatremia, as discussed in Chapter 19. Vascular lesions were found in six patients: five had multiple cerebral infarcts (one terminal), and one who had thrombocytopenia before death had brain purpura. We have had only two autopsies in our prospective series, and neither showed abnormalities in the brain.

The significance of the aforementioned pathological findings is not clear, mainly because these patients had been septic for weeks. There is no way of knowing with certainty when the lesions found at autopsy actually developed. It is possible that focal signs and seizures could have been produced by the lesions, but the microabscesses and vascular lesions were small and multifocal. Furthermore, occasionally focal signs and focal seizures can occur in metabolic encephalopathies.

In a literature search, we could not find a study of encephalopathy in septic humans comparable to ours. As we reported in this chapter in the third edition of this book, "watershed" cerebral infarctions have been described in patients who died of septic shock, but without clinical correlations. Such watershed infarcts are ischemic lesions at or near the terminal portions of the anterior, middle, and posterior cerebral arteries, and they are typically associated clinically with bibrachial paralysis, which we have never encountered in our patients. Other authors have chosen cases with microabscesses at postmortem examination, rather than starting with clinically septic patients. There is one report of a patient dying of sepsis due to a breast abscess who showed sagittal sinus thrombosis and thrombophlebitis of cerebral cortical veins.

Pathogenesis {#cesec5}
------------

The pathogenesis of septic encephalopathy remains uncertain; however, there are a number of possible mechanisms that are not mutually exclusive. Since mild cases resolve without sequelae, it is likely that reversible, metabolic factors are operative. The cases with neurological deficits may have one or more of the structural lesions we have found at postmortem; for example, multifocal, microscopic ischemic lesions and microabscess of the brain.

The principal chemical mediators of the sepsis syndrome are cytokines, chemical messengers released from lymphocytes and macrophages. These play a key role in the alteration of the microcirculation of the brain ([Fig. 52-1](#f1){ref-type="fig"}), increased blood--brain barrier, altered metabolism of the body, and derangements of the brain\'s extracellular milieu and neurotransmitter balance.

Multifocal brain ischemia may relate to activation of "adhesion molecules," the selectin and integrin group, causing leukocyte adherence or "rolling leukocytes," which may be an early cause of endothelial cell damage.[@bib5] This affects nitric oxide synthesis by the endothelium. Nitric oxide is the "vascular relaxing factor"; its synthesis is increased by endotoxin and cytokines in sepsis, leading to reduced peripheral vascular resistance and hypotension. Although this seems counterproductive, such multifocal vasodilatation helps ensure adequate organ perfusion in sepsis; inhibition of nitric oxide production can lead to decreased organ perfusion and a fall in oxygen extraction by tissues.[@bib16] Nitric oxide plays an important role in regulating brain circulation and the permeability of the blood--brain barrier.[@bib17] Endothelial damage in sepsis may then compromise regional cerebral blood-flow and account for the multifocal, dynamic increases in blood--brain (and possibly blood--nerve) permeability mentioned earlier. Uncommonly, brain lesions relate to focal brain or disseminated intravascular coagulation.

An increase in blood--brain barrier permeability in SIRS can produce multifocal vasogenic edema and alter the composition of the brain\'s extracellular fluid. Tumor necrosis factor--alpha and interferon-gamma increase the permeability of cerebral endothelial cells.[@bib18], [@bib19] It has also been shown that the perivascular end-feet of astrocytes are disrupted in pigs with fecal peritonitis injected with endotoxin.[@bib20] Alterations in the adrenergic system may also play a role: the β~2~-adenoreceptor agonist dopexamine inhibits brain edema in animal models of sepsis, while the α~1~-adenoreceptor blocker methoxamine prevents it. The combined effect increases tissue edema and alters the chemical milieu of the interstitial fluid of the brain. Cytokines themselves may directly affect brain function. Again, their access to the brain may be facilitated by alterations in blood--brain barrier function. When directly injected into the brain or ventricles of animals, interleukin-1 and interleukin-2 alter behavior and EEG frequencies.[@bib21] Interleukin-1 facilitates sleep and induces fever by its effects on the hypothalamus. Some of these effects relate to activation of opiate receptors in the brain; the possibility of effects on other peptide systems in the brain remains to be explored. Proinflammatory cytokines may also activate STAT 3, a transcription molecule, in astrocytes.[@bib22] The significance of this is not clear, but astrocytes play a key role in maintaining a homeostatic environment for CNS neurons. Lipopolysaccharides and proinflammatory cytokines, including interferon-gamma, upregulate inducible nitric oxide synthase (i-NOS) in astrocytes.[@bib23] This leads to the production of reactive oxygen species such as nitric oxide and superoxide, causing oxidative stress for astrocytes and neurons of the brain.

Transport of amino acids across the blood--brain barrier is altered in sepsis; that is, there is an alteration in transcapillary transport systems. This could alter the chemical milieu of the brain cells; substances normally excluded from the brain may gain access to neuronal receptors. These include drugs as well as the relative amounts of certain endogenous substances. The latter include higher ratios of aromatic to branched-chain amino acids (increased in the plasma because of altered metabolism in liver and muscle) and increased exposure to other peptides and hormones. Such changes play a role in the documented alteration of certain putative neurotransmitters in sepsis, such as serotonin, norepinephrine, and dopamine. Additional neurotransmitter alterations include increased serotonin turnover and decreased noradrenergic transmission in the brain in sepsis.[@bib24] A similar derangement in neurotransmitter balance occurs in hepatic and uremic encephalopathy. Astrocytic dysfunction, mentioned earlier, contributes to increases in extracellular glutamate, an excitotoxic neurotransmitter that can cause neuronal death or seizures through activation of *N*-methyl-d-aspartate (NMDA) receptors.[@bib25]

The brain may also be affected indirectly because of the failure or altered metabolism of other organ systems. Within 5 hours from the onset of sepsis, the liver shows impaired ability to clear indocyanine green. We have found an elevated serum bilirubin concentration in sepsis, with a direct relationship to the severity of the encephalopathy.[@bib12] Endogenous benzodiazepine-like substance is also increased in hepatic failure.[@bib26] Although this has not been explored in sepsis, we have found that some patients with septic encephalopathy may improve with flumazenil, a γ-aminobutyric acid--A antagonist, even in the absence of exogenous benzodiazepines (unpublished observations).

In advanced sepsis, the failure of other organs (e.g., kidneys, heart) may, in turn, affect brain function and lead to an encephalopathy.

In intensive care, iatrogenic factors should always be considered. Sedative drugs, particularly opiates and benzodiazepines, are commonly used to ease the use of assisted ventilation. If renal impairment occurs, opiate clearance is reduced, and this may lead to prolonged obtundation. Brain function of critically ill patients, as reflected by the EEG, is highly sensitive to midazolam; the same probably applies to other benzodiazepines.[@bib27] On a clinical basis it is difficult to determine whether encephalopathy is due to sepsis, sedative drugs, or both. Daily interruption of sedative drugs may partially overcome this difficulty.[@bib28] Continuous EEG monitoring may also be helpful.

Total parenteral nutrition is sometimes associated with hypophosphatemia or hyperosmolality, both of which may cause coma. High serum levels of penicillin, usually in association with renal impairment, may cause seizures, as may the newer antibiotic imipenem.[@bib29] Central pontine myelinolysis may complicate the sudden increases of plasma osmolality in critically ill patients.

In summary, there are multiple, non--mutually exclusive mechanisms to explain septic encephalopathy. Many of these are reversible, but some mechanisms may lead to neuronal death, for example, oxidative stress, excitotoxicity, microinfarctions or osmotic demyelination. These are summarized in [Figure 52-3](#f3){ref-type="fig"} .FIGURE 52-3This graphic represents the three principal cell types relevant to septic encephalopathy: the endothelial cell in brain capillaries, the astrocyte, and the neuron. Conceptually the encephalopathy can be divided into dysfunction that is reversible or irreversible, with structural changes in the brain. Further discussion is provided in the text. AA, amino acid; ARAS, ascending reticular activating system; BBB, blood--brain barrier; fx, function; rCBF, regional cerebral blood-flow.(From Wilson JX, Young GB: Progress in Neurosciences: Sepsis-associated encephalopathy---evolving concepts. Can J Neurol Sci 2003;30:98, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

NEUROMUSCULAR PROBLEMS IN THE CRITICAL CARE UNIT {#cesec6}
================================================

The list of conditions that can affect the neuromuscular system in patients in the critical care unit is remarkably long and potentially involves dysfunction of the entire nervous system ([Table 52-2](#cetable2){ref-type="table"} ). To pinpoint the site of dysfunction may be extremely difficult, especially in the setting of the critical care unit. History taking is often impossible, as an endotracheal tube prevents speech, and the often associated encephalopathy prevents reliable communication of any type. The limbs are not easily assessed, owing to the presence of intravenous lines, splints, bandages, and so forth. Thus, although a neurological examination tailored to the comatose patient may provide some assessment of the nervous system, we have found that the presence and severity of either brain or peripheral nervous system dysfunction is often difficult to document by purely clinical methods.TABLE 52-2Differential Diagnosis of Neuromuscular Signs in Critically Ill Patients***Encephalopathy***SepticAnoxic-ischemicOther***Myelopathy***Anoxic-ischemicTraumaticOther***Neuropathy***Critical illness polyneuropathyThiamine deficiencyVitamin E deficiencyNonspecific nutritional deficiencyPyridoxine abuseHypophosphatemiaAminoglycoside toxicityPenicillin toxicityGuillain--Barré syndromeMotor neuron diseasePorphyriaCarcinomatous polyneuropathyCompression neuropathyDiphtheria***Neuromuscular Transmission Defects***Neuromuscular blocking agentsAminoglycoside toxicityMyasthenia gravisLambert--Eaton myasthenic syndromeHypocalcemiaHypomagnesemiaOrganophosphate poisoningWound botulismTick-bite paralysis***Myopathy***Critical illness (myosin-deficient) myopathyCachexiaAcute rhabdomyolysisAcute necrotizing myopathy of intensive careElectrolyte disturbances: potassium, phosphate, calcium, magnesiumCorticosteroid myopathyMuscular dystrophyPolymyositisAcid maltase deficiency

De Jonghe and co-workers in France tested muscle strength in critically ill patients when they became alert enough to voluntarily activate the muscles.[@bib30] However, they found weakness in only 25 percent, less than half of those identified by electrophysiological methods.[@bib10] Thus, we routinely use electrophysiology to assess such patients. Using electrophysiological tests, we have found that both septic encephalopathy and critical illness polyneuropathy are almost invariable manifestations of the sepsis and multiple organ failure syndrome, and the other conditions listed in the table are only rarely involved. In fact, these other conditions are usually evident before the patient has been admitted to the critical care unit and are the obvious reason for neuromuscular respiratory failure. Myasthenia gravis and Guillain--Barré syndrome are good examples, although in some instances it is necessary to exclude these conditions systematically. Repetitive nerve stimulation may be required to investigate for a defect in neuromuscular transmission. Such studies have revealed the presence of myasthenia gravis or the Lambert--Eaton myasthenic syndrome not previously suspected.[@bib31], [@bib32] Electrophysiological studies may disclose motor neuron disease for the first time.[@bib33] Muscle biopsy may be necessary to exclude primary myopathies such as polymyositis or a metabolic disturbance such as acid maltase deficiency. Except for critical illness polyneuropathy, the Guillain--Barré syndrome is, in our experience, the most common neuromuscular problem seen in the unit. It can almost invariably be recognized by clinical features occurring prior to admission to the critical care unit, by the pattern of abnormalities on electromyography (EMG) and nerve conduction studies, and by CSF examinations.

The following sections focus on the major neuromuscular conditions to be considered in critically ill patients being managed in critical care units.

Critical Illness Polyneuropathy {#cesec7}
-------------------------------

Critical illness polyneuropathy ([Table 52-3](#cetable3){ref-type="table"} ) is a predominantly motor, axonal polyneuropathy occurring as a complication of the systemic inflammatory response (septic) syndrome in 50 to 70 percent of patients with that syndrome.[@bib34], [@bib35], [@bib36], [@bib37], [@bib38] Since as many as 50 percent of patients in major medical and surgical critical care units have the syndrome, critical illness polyneuropathy must now be regarded as a particularly common neuromuscular disorder. Critical illness myopathy may be common in units that frequently use neuromuscular blocking agents and steroids.[@bib39] TABLE 52-3Generalized Neuromuscular Conditions Associated With Critical IllnessConditionIncidenceClinical FeaturesElectrophysiological FindingsSerum Creatine Kinase LevelMuscle BiopsyPrognosis***Polyneuropathy***Critical illness polyneuropathyCommonFlaccid limbs and respiratory weaknessAxonal degeneration of motor and sensory fibersNearly normalDenervation atrophyVariable***Neuromuscular Transmission Defect***Transient neuromuscular blockadeCommon with neuromuscular blocking agentsFlaccid limbs and respiratory weaknessAbnormal repetitive nerve stimulation studiesNormalNormalGood***Critical Illness Myopathy***Thick-filament myosin lossCommon with steroids, neuromuscular blocking agents, and sepsisFlaccid limbs and respiratory weaknessAbnormal spontaneous activityMildly elevatedLoss of thick (myosin) filamentsGoodRhabdomyolysisRareFlaccid limbsNear normalMarkedly elevated (myoglobinuria)Normal or mild necrosisGoodNecrotizing myopathy of intensive careRareFlaccid weakness and myoglobinuriaSevere myopathyMarkedly elevated, myoglobinuriaMarked necrosisPoorDisuse (cachectic) myopathyCommon?Muscle wastingNormalNormalNormal or type II fiber atrophyGoodCombined polyneuropathy and myopathyCommonFlaccid limbs and respiratory weaknessIndicate combined polyneuropathy and myopathyVariableDenervation atrophy and myopathyVariable

The first, and often the only, clinical sign of critical illness polyneuropathy is respiratory muscle weakness, manifested as a difficulty in weaning from the mechanical ventilator. Other neuromuscular causes of difficulty in weaning may be trauma to the phrenic nerve, neuromuscular transmission defect, primary myopathy, and disorders of central drive due to an associated encephalopathy.[@bib31] In severe critical illness polyneuropathy there are weak or absent movements of the limbs, even when the limbs are stimulated distally by pressure over the nail beds. Tendon reflexes that were previously present cannot be elicited. By contrast, head, face, and jaw movements are relatively preserved. In two of our patients, this absence of movement in the extremities but preservation of movement of the head had erroneously been diagnosed as resulting from high cervical spinal cord disease. Patients with lesser degrees of polyneuropathy show more equivocal signs, with variably weak muscles, particularly distally, and reduced or absent tendon reflexes, notably at the ankles. However, many patients have no clinical signs of neuromuscular disease. The polyneuropathy tends to be more severe the longer that the patient is in the unit.

Electrophysiological studies clearly establish the presence of a peripheral neuropathy and document its severity.[@bib38] Upper- and lower-limb motor and sensory conduction studies initially reveal only a reduction in the amplitude of compound muscle and sensory nerve action potentials, with no change in latency or conduction velocity. The duration of the compound muscle action potential (CMAP) may be prolonged, suggesting primary dysfunction of the muscle fiber membrane in addition to denervation ([Fig. 52-4](#f4){ref-type="fig"} ).[@bib10] Then, within a matter of 2 weeks, fibrillation potentials and positive sharp waves appear in muscle, and sensory and compound muscle action potentials are further reduced. Even in the more advanced stages of critical illness polyneuropathy, conduction velocity and distal latencies remain relatively normal, emphasizing the purely axonal, degenerative nature of the neuropathy.FIGURE 52-4Measurement of compound thenar muscle action potentials at the onset of sepsis **(A)** and 3 weeks later **(B).** Note the marked decline in amplitude and increase in duration, without change in latency, on stimulation of the median nerve at the wrist and elbow. These changes suggest primary dysfunction of the muscle fiber membrane in addition to denervation.(From Bolton CF: Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med 19:1179, 2000, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Comprehensive examination of the entire nervous system at autopsy, plus nerve and muscle biopsy, has revealed that there is a primary axonal degeneration of motor and sensory fibers, particularly involving distal nerve fibers ([FIGURE 52-5](#f5){ref-type="fig"}, [FIGURE 52-6](#f6){ref-type="fig"} ).[@bib36], [@bib40] There is a resulting denervation atrophy of muscle; histopathological examination during the acute phase reveals scattered, angulated fibers and later shows grouped atrophy ([Fig. 52-7](#f7){ref-type="fig"} ). Neither the nerve nor the muscle shows any inflammatory change. Aside from chromatolysis of the anterior horn cells secondary to the peripheral axonal injury, the CNS is spared. Axonal degeneration of intercostal and phrenic nerves and denervation atrophy of respiratory muscles explain the respiratory insufficiency. Latronico and associates found that some patients have abnormal electrophysiological but normal biopsy findings of nerve and muscle, suggesting that functional changes precede structural alterations.[@bib40] FIGURE 52-5Transverse section of the superficial peroneal nerve showing severe axonal degeneration and loss of myelinated fibers. (Toluidine blue; original magnification 773×.)(From Zochodne DW, Bolton CF, Wells GA, et al: Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 110:819, 1987, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.FIGURE 52-6Longitudinal section of the deep peroneal nerve demonstrating axonal degeneration and loss of myelinated fibers. (Toluidine blue; original magnification 778×.)(From Zochodne DW, Bolton CF, Wells GA, et al: Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 110:819, 1987, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.FIGURE 52-7Transverse section of iliopsoas muscle showing scattered and grouped atrophic fibers consistent with denervation atrophy. (Hematoxylin and eosin; original magnification 195×.)(From Zochodne DW, Bolton CF, Wells GA, et al: Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 110:819, 1987, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

The mechanism of the polyneuropathy is not known. However, our investigations have excluded potential causes of polyneuropathy, including Guillain--Barré syndrome, various toxins, drugs (particularly antibiotics), and nutritional deficiency.[@bib41] It is our belief that the polyneuropathy is probably caused by the same fundamental defect that affects all organ systems in the critical illness syndrome through involvement of the microcirculation ([Fig. 52-1](#f1){ref-type="fig"}). We speculate[@bib41] that the primary axonal damage may be due to involvement of axonal transport systems, which are known to be energy-dependent; this fact may explain why predominantly distal nerve segments are involved. Moreover, it is known that the blood--nerve barrier, in contrast to the blood--brain barrier, shows increased permeability to histamine and serotonin. Several mediators of the septic syndrome are known to have histamine-like action. Circulating "toxins" could potentially gain access to the endoneurial space and directly damage the axon. It is also possible that disturbance of the microcirculation, as has been postulated to occur in sepsis and multiple organ failure, is the mechanism by which these events in peripheral nerve are initiated.

Our studies provide no evidence that the use of antibiotics causes the polyneuropathy. Indeed, because successful treatment of the sepsis results in improvement in the polyneuropathy, we advise that all medical and surgical means of improving the sepsis and multiple organ failure be instituted. Moreover, all critical care units should use whatever methods are necessary to avoid sepsis (e.g., use of sterile techniques and avoidance of invasive procedures unless absolutely necessary). Although we have no evidence that the polyneuropathy is due to nutritional deficiency, it seems prudent to administer total parenteral or enteral nutrition from the start of critical illness. Those individuals responsible for physical therapy and rehabilitation should be aware of the nature and severity of the polyneuropathy, so that they will take it into account as the patient gradually recovers.[@bib42]

Intravenous immune globulin has been widely used to treat sepsis but appears to have little effect on critical illness polyneuropathy.[@bib43], [@bib44] Interventions to interrupt the septic cascade utilizing monoclonal and polyclonal antibodies directed against bacterial endotoxin, oxygen radical scavengers, platelet activating factor receptor antagonists, and hemofiltration techniques and plasma exchange have had little effect on the septic syndrome.[@bib10] Administration of recombinant activator protein 1 to reduce intravascular thrombosis improved morbidity and mortality, but polyneuropathy was not evaluated.[@bib2]

The most interesting recent development was the well-designed study by van den Berghe and associates showing that better control of blood glucose levels utilizing insulin not only improves morbidity and mortality but also reduces the incidence of critical illness polyneuropathy.[@bib45]

Motor Neuropathy and Neuromuscular Blocking Agents {#cesec8}
--------------------------------------------------

Polyneuropathy may develop in patients who have been in the critical care unit for several days, or possibly weeks, and received competitive neuromuscular blocking agents, such as pancuronium bromide or the shorter-acting vecuronium, to ease mechanical ventilation.[@bib10] These agents will have been used for longer than 48 hours, occasionally for days or weeks. When these agents are discontinued, difficulty in weaning the patient from the ventilator and limb paralysis are noted. The serum creatine kinase (CK) level is mildly or moderately elevated. Electrophysiological testing sometimes reveals a defect in neuromuscular transmission. If present, it will be demonstrated on slower rates of stimulation, as expected with a postsynaptic defect. There is evidence of severe primary axonal degeneration of predominantly motor fibers on nerve conduction and needle EMG studies. Muscle biopsy shows varying degrees of denervation atrophy and muscle necrosis.

Although the mechanism of this neuropathy is unknown, we believe that sepsis is an important underlying factor in the condition of most, if not all, of these patients.[@bib38] Thus, if the various systemic complications can be treated successfully, the neuromuscular condition itself improves spontaneously and good recovery may occur, sometimes quite rapidly. We[@bib36], [@bib38] and others[@bib37], [@bib40], [@bib46] have failed to implicate neuromuscular blocking agents as a cause of critical illness polyneuropathy. However, the neuromuscular blocking agent probably has an additional toxic effect on nerve and muscle, and its use should be avoided, if possible.

Chronic Polyneuropathies {#cesec9}
------------------------

Occasionally, chronic polyneuropathies will evolve as rapidly developing respiratory insufficiency. Although rare, this may occur in chronic inflammatory demyelinating polyneuropathy and diabetic polyneuropathy. It is generally worthwhile to undertake phrenic nerve conduction studies and needle EMG of the diaphragm to show clearly that the respiratory insufficiency is due to the neuropathy. Such studies complement the conventional electrodiagnostic studies that document the presence of a polyneuropathy.

Neuromuscular Transmission Disorders and Myopathies {#cesec10}
---------------------------------------------------

As noted previously, neuromuscular transmission disorders and myopathies are more varied and complex and may be difficult to distinguish from critical illness polyneuropathy and especially from the motor axonal neuropathy or critical illness myopathy that may be associated with the SIRS and the use of competitive neuromuscular blocking agents and steroids. Electrophysiological studies, measurements of blood CK level, and at times muscle biopsy will usually further define the nature of the muscular weakness ([Table 52-3](#cetable3){ref-type="table"}).

### Transient Neuromuscular Blockade {#cesec11}

Competitive neuromuscular blocking agents, often used to ease mechanical ventilation, are metabolized or cleared by the liver and kidney. Hence, in the presence of failure of these organs, the effect of the neuromuscular blocking agent may be prolonged for a number of days after it has been discontinued.[@bib47] Repetitive stimulation studies will correctly identify the defect in neuromuscular transmission. However, by the time of testing, many of these patients will already have developed an underlying critical illness polyneuropathy in addition to a neuromuscular transmission defect, each disclosed by electrophysiological studies. Recovery may be prolonged for several weeks or even months in severe cases.

### Critical Illness Myopathy {#cesec12}

An acute myopathy often affects critically ill patients. Whereas acute quadriplegic myopathy[@bib48] has been the most common designation, others include critical care myopathy, acute necrotizing myopathy of intensive care, thick filament myopathy, critical illness myopathy, acute corticosteroid myopathy, acute hydrocortisone myopathy, acute myopathy in severe asthma, and acute corticosteroid and pancuronium--associated myopathy. The term *critical illness myopathy* is now considered the most appropriate description for this syndrome.[@bib49] By definition, patients are or were critically ill, and weakness should have started after the onset of critical illness.

Critical illness myopathy may occur independently of, or in association with, critical illness polyneuropathy. De Letter and co-workers showed a relationship between the early onset and severity of critical illness polyneuropathy and myopathy and Apache III scores, which measure the severity of critical illness and sepsis.[@bib50] Critical illness myopathy develops in at least one third of ICU patients treated for status asthmaticus,[@bib51] in 7 percent of patients after orthoptic liver transplantation,[@bib52] and in patients after heart transplant.[@bib53] It may occur in the severe acute respiratory syndrome (SARS), even though there is no evidence of virus on culture and electron microscopy.[@bib54] In a prospective study by Trojaborg and colleagues,[@bib55] all 22 critically ill patients showed clinical, electrophysiological, and muscle biopsy evidence of a primary myopathy.

The major feature is flaccid weakness, which tends to be diffuse, involving all limb muscles and the neck flexors and often the facial muscles and diaphragm. Thus, most patients are difficult to wean from mechanical ventilation. Ophthalmoplegia may be present.[@bib56] Tendon reflexes are often depressed, but normal reflexes do not exclude the diagnosis. Myalgias are uncommon. Although the myopathy develops acutely, the time of onset is usually difficult to determine because of the commonly associated encephalopathy and administration of neuromuscular blocking agents.

Nerve conduction studies reveal low-amplitude CMAPs, some of which may be of long duration ([Fig. 52-4](#f4){ref-type="fig"}). Park and co-workers observed this prolongation in every muscle tested in patients with critical illness myopathy.[@bib57] The sensory nerve action potentials (SNAPS) should be normal but may be reduced in amplitude owing to tissue edema. Near-nerve recordings overcome this difficulty. Examination of motor unit potentials may be impaired by the attendant septic encephalopathy and sedation. This difficulty may be partially overcome by recording from the tibialis anterior muscle and activating motor units by plantar stimulation. Fibrillation potentials and positive sharp waves will be present in both critical illness myopathy and neuropathy. In critical illness myopathy, motor unit potentials are of low amplitude and short duration, with high-frequency components. Quantitative studies of motor unit potentials confirm that their duration is decreased.[@bib55] However, such units are also seen in critical illness polyneuropathy with predominantly distal motor axonopathy, as demonstrated in single-fiber studies.[@bib58] Electrical inexcitability of the muscle membrane can be demonstrated by direct needle stimulation of the muscle[@bib59] in patients with severe critical illness myopathy and markedly reduced or absent CMAPs.[@bib60] In critical illness polyneuropathy, there is a response to direct muscle stimulation but not to stimulation of the nerve supplying the muscle. Direct muscle stimulation may therefore be helpful in the differentiation of these two disorders.[@bib61], [@bib62] However, the results of direct muscle stimulation are only semiquantitative, and this, coupled with the coexistence of critical illness neuropathy and myopathy, may make interpretation difficult. Trojaborg has proposed an electrophysiological approach using the methods noted, plus motor unit estimate techniques.[@bib63] A more consistent and easily measured response is the duration of the CMAP, which is increased in duration in a manner consistent with a primary myopathy ([Fig. 52-4](#f4){ref-type="fig"}).

Determination of serum CK level may be helpful in differential diagnosis ([Table 52-3](#cetable3){ref-type="table"}). Markedly elevated levels suggest a necrotizing myopathy,[@bib64], [@bib65] whereas in other types of critical illness myopathy the serum CK elevations are not so severe and may be delayed for 10 days or more after administration of steroids.[@bib66] By contrast, serum CK levels in critical illness polyneuropathy are normal or only mildly elevated.[@bib36]

Phrenic nerve conduction studies and needle EMG of the diaphragm and chest wall muscles are valuable in assessing patients with suspected critical illness myopathy.[@bib67] Phrenic nerve conduction studies typically show normal latencies but diaphragm CMAP amplitudes may be reduced, with a return toward normal as recovery occurs. Needle EMG may reveal positive sharp waves and fibrillation potentials in respiratory muscles. Motor unit potentials may be difficult to interpret in the diaphragm because they normally have a "myopathic" appearance.

Identification of the subtypes of critical illness myopathy, as described here, may aid in prognostication ([Table 52-3](#cetable3){ref-type="table"}).[@bib10]

#### Thick-Filament Myosin Loss {#cesec13}

This syndrome, frequently termed *acute quadriplegic myopathy,* occurs in the setting of sudden, severe asthma or in post-transplant patients requiring tracheal intubation and placement on a ventilator in combination with high-dose corticosteroids and neuromuscular blocking agents. It is a rare complication in critically ill children, post-transplant children being especially at risk.[@bib68] Serum CK levels may be elevated only mildly. Muscle biopsy shows destruction of the thick myosin filaments, often seen on light microscopy but found more definitively on electron microscopy. The typical histopathological features are shown in [FIGURE 52-8](#f8){ref-type="fig"}, [FIGURE 52-9](#f9){ref-type="fig"} .[@bib69] There is no specific treatment. The best approach is to avoid neuromuscular blocking agents and, especially, steroids, or to use these medications as sparingly as possible.FIGURE 52-8Both histochemical type 1 and type 2 fibers show extensive central pallor. Myofibrillar ATPase (pH 9.4; 50×).(From Danon MJ, Carpenter S: Myopathy and thick filament \[myosin\] loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14:1131, 1991, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.FIGURE 52-9At high magnification, central, sharply bounded A-band loss contrasts with its peripheral preservation. (Epoxy resin section, paraphenylene diamine, phase optics 1380×.)(From Danon MJ, Carpenter S: Myopathy and thick filament \[myosin\] loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14:1131, 1991, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

#### Rhabdomyolysis {#cesec14}

Rhabdomyolysis occurs in the setting of critical illness and the use of neuromuscular blocking agents and corticosteroids.[@bib70] It may be due to a variety of causes and presents with weakness, myalgia, and swelling in the affected muscles. Massive muscle necrosis results in the release of potassium and initially sequesters calcium. The resultant hyperkalemia and hypocalcemia may produce life-threatening cardiac arrhythmias and renal failure. Serum CK level is elevated, often to greater than 10,000 IU/L. Myoglobinuria occurs frequently. The electrophysiological findings are those of an acute myopathy. Motor and sensory nerve conduction studies are usually normal. On needle EMG, fibrillation potentials are usually sparse and transient and motor unit potentials often normal.[@bib71] Muscle biopsy may be normal or show varying degrees of myofiber necrosis without inflammation, myosin loss, or other specific features. Thus, despite considerable weakness and elevated serum levels of CK, EMG and muscle biopsy are often unimpressive, consistent with rapid and complete recovery.

During bacteremia, microabscesses may be deposited throughout skeletal muscle and present the clinical picture of acute rhabdomyolysis. Blood culture will identify the offending organism, and muscle biopsy will identify the microabscesses. This is a variant of pyomyositis typically seen in tropical countries or in children.[@bib10]

#### Acute Necrotizing Myopathy {#cesec15}

Acute necrotizing myopathy of intensive care[@bib64], [@bib65] may be simply an extension of acute rhabdomyolysis and is induced by the same variety of infective, chemical, and other insults. Serum CK levels are markedly elevated, myoglobulinuria is present, electrophysiological examinations suggest a severe myopathy, and pathological studies show widespread necrosis of muscle fibers. Recovery of muscle strength may not occur in severe cases.[@bib65]

#### Cachectic Myopathy {#cesec16}

Muscle weakness and wasting commonly occur in starvation and malnutrition, as in anorexia nervosa or following gastric bypass surgery for morbid obesity[@bib72], [@bib73] and are termed *cachectic myopathy* or *disuse atrophy*. It is likely a common complication of critical illness and accounts for significant wasting and weakness of muscle. Electrophysiological findings and serum CK levels are normal. Muscle biopsy is normal or reveals type II fiber atrophy. The diagnosis of cachectic myopathy is made by exclusion of other neuromuscular complications of critical illness.

#### Management of Critical Illness Myopathy {#cesec17}

Whether a clinician should routinely pursue a muscle biopsy in order to distinguish critical illness myopathy from other myopathies or from critical illness polyneuropathy is questionable. Muscle biopsy should be considered if another myopathic process, such as an inflammatory myopathy, is suspected or if the histological findings may affect management. For example, a firm diagnosis of critical illness myopathy may lead to avoidance of intravenous corticosteroids or neuromuscular blocking agents. As indicated in [Table 52-3](#cetable3){ref-type="table"}, the various types of critical illness myopathy can be distinguished by clinical, electrophysiological, and histological features.[@bib10] This is important for prognosis. Severe critical illness polyneuropathy and necrotizing myopathy of intensive care[@bib64] may have a poor prognosis for recovery of strength, but the prognosis is much better for rhabdomyolysis, cachectic myopathy, and thick filament myosin loss.

### Critical Illness Polyneuropathy and Myopathy {#cesec18}

The predominance of either critical illness polyneuropathy or myopathy in individual patients probably varies depending on the use of neuromuscular blocking agents and corticosteroids. Thus, in an ICU where these medications were used in post-transplant patients, the incidence of critical illness myopathy was high[@bib39]; by contrast, in another ICU where there were no post-transplant patients and neuromuscular blocking agents and steroids were rarely used, the incidence of myopathy was low.[@bib38] Sepsis is likely the predominant underlying factor, with the additional factors of neuromuscular blocking agents and corticosteroids combining to account for the pathophysiology ([Fig. 52-10](#f10){ref-type="fig"} ).FIGURE 52-10A simplified depiction of theoretical mechanisms of dysfunction in critical illness polyneuropathy and myopathy. Sepsis with disturbance of microcirculation is a common underlying factor, neuromuscular (N-M) blocking agents enhance denervation, and corticosteroids subsequently induce a myopathy with thick-filament myosin loss. Varying pathological changes in muscle may result. In the early stages of sepsis, there may be a purely functional loss, with no structural change in nerve or muscle.(From Bolton CF: Neuromuscular complications of sepsis. Intensive Care Med 19:S58, 1993, with permission.)© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

The range of severity of combined critical illness polyneuropathy and myopathy may be quite marked.[@bib10] Despite severe respiratory and limb weakness with electrophysiological evidence of predominant involvement of muscle and marked elevations of serum CK, the patient may make a rapid recovery if the muscle biopsy is normal. Conversely, recovery may not occur in patients with clinical and electrophysiological evidence of severe involvement of both nerve and muscle, high levels of serum CK, myoglobin in the urine, and necrosis of muscle on morphological study. Latronico and associates reported that 74 of 263 patients (28%) with combined critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) were left with severe disability.[@bib74]

ELECTROPHYSIOLOGICAL STUDIES OF THE RESPIRATORY SYSTEM {#cesec19}
======================================================

The techniques of phrenic nerve conduction and needle EMG of the diaphragm have proved of great value in establishing that respiratory insufficiency is due to a neuromuscular disorder. The techniques can indicate impairment of "central drive" as a disturbance of the voluntary or automatic centers of respiration, or impairment of phrenic nerves, neuromuscular junction, or muscle. For example, in patients with Guillain--Barré syndrome, the degree of involvement of the phrenic nerves can be determined and will supplement measurements, including of vital capacity, in determining the need for respiratory assistance.[@bib75]

Documenting the degree of axonal degeneration or demyelination of phrenic nerves aids in long-term prognostication. In a study of 40 patients who had difficulty in weaning from the ventilator when a neuromuscular cause was suspected, 38 were shown to have such a disorder.[@bib76] In an earlier study, Spitzer and associates also found a high incidence of both polyneuropathy and myopathy as causes of prolonged difficulty in weaning.[@bib77] Most had critical illness polyneuropathy, but there were varying combinations of unilateral phrenic nerve damage, neuromuscular transmission defects, and primary myopathies. Combined electrophysiological studies of limbs and the respiratory system are therefore of assistance in identifying these conditions and rendering a prognosis.

MONONEUROPATHIES {#cesec20}
================

A variety of mononeuropathies may occur in patients being treated in the critical care unit. Lumbosacral or brachial plexopathies may be secondary to direct trauma, usually from motor vehicle accidents or surgery. Insertion of catheters into the iliac arteries or aorta may dislodge thrombi, and the resulting emboli impair vascular supply to nerves and, in this manner, induce focal ischemic plexopathy. Direct surgical trauma to vessels may also induce vascular insufficiency.

Motorcycle accidents commonly injure the brachial plexus. Proximal lesions are suggested by Horner\'s syndrome, winging of the scapula, and diaphragm paralysis. Electrophysiological studies, ideally performed after 3 weeks, further help to localize the lesion. Myelography, CT myelography, or magnetic resonance imaging (MRI) may provide more positive evidence of root avulsion, which would preclude attempts at operative nerve repair. Fractures of the pelvis may cause varying patterns of damage to the lumbosacral plexus.

Observations of focal weakness on reflex-induced voluntary movement, plus abnormalities of the tendon reflexes, may provide an initial clue to the presence of such damage. Thus, weakness of hip adduction and flexion and of knee extension and an absent patellar reflex suggest damage to the L2--L4 roots of the lumbosacral plexus.

Electrophysiological studies should successfully demonstrate abnormalities on motor and sensory nerve conduction studies and, in particular, needle EMG should localize the lesion to the brachial or lumbosacral plexus.

There are several types of mononeuropathies. If the patient\'s primary reason for admission to the unit was the postoperative state, the initial surgery may have induced a mononeuropathy when operating room equipment, or perhaps the surgery itself, directly damaged peripheral nerves, since a variety of limb nerves may be damaged by trauma. For example, weakness of dorsiflexion of the wrist and digits and an absent brachioradialis reflex suggest radial nerve damage in the spiral groove of the humerus by fracture or direct compression. Phrenic nerves may be damaged, either bilaterally or unilaterally, at the time of surgery by direct trauma or by the application of cold, as occurs with the hypothermia associated with cardiac surgery.

More distal nerves may be damaged as the result of impairment of nutrient blood supply through distal embolization. Thus, following cardiac or vascular surgery, patients may have varying combinations of involvement of femoral or sciatic nerves. Electrophysiological studies show a relatively pure axonal degeneration of motor and sensory fibers.

Patients who are being anticoagulated run the risk of hemorrhage. The sudden rise in tissue pressure produces a "compartment syndrome," the severe compression resulting in ischemia to nerve, as well as muscle. The compartments most commonly involved are the iliopsoas and gluteal, producing acute femoral or sciatic neuropathies. Fractures and soft tissue trauma may also induce compartment syndromes. An immediate CT scan should be ordered, which will show the location of the hemorrhage. Then, surgical decompression may successfully decompress the nerve. The situation is so acute and urgent that electrophysiological studies are of little value.
